BIO-UV Group S.A. (ALTUV.PA) • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold ALTUV.PA in your mock portfolio yet.
With EPS of €0.06 and a PE ratio of 22.67, BIO-UV Group S.A. is priced at a moderate earnings multiple that implies some growth expectations despite modest absolute profitability. The valuation does not appear distressed, but the low EPS level suggests limited current earnings power and likely thin margins. Overall, the financial picture looks stable rather than strongly expanding or deeply challenged based on the limited data provided.
The stock trades at €1.36, below its 200-day moving average of €1.46, indicating a prevailing downward or at least weak medium-term trend. A 2.9% decline over the last month reinforces the picture of soft recent momentum. Without evidence of oversold conditions (e.g., RSI not provided but price below 200-day MA and recent decline suggest pressure), the technical setup leans cautious to bearish in the near term.
Website traffic at roughly 4,161 monthly visitors is modest and there is no sign of strong growth or contraction implied, suggesting a relatively stable but small digital footprint. Hiring activity is flat with only 1 open role and 0.0% month-over-month change, indicating no clear expansion or retrenchment. Social media presence is small but broadly stable, with slight declines on Twitter/X and Facebook offset by a small increase on YouTube and a relatively larger LinkedIn following, pointing to a steady but not rapidly scaling commercial profile.
Overall, BIO-UV Group S.A. presents a neutral setup: fundamentals show modest profitability with a valuation that assumes some improvement, while technicals are weak and alternative data is broadly stable but unspectacular. The stock trading below its 200-day moving average and posting a recent monthly decline tilts the near-term bias slightly cautious, yet the absence of clear distress in earnings or alternative signals tempers a strongly negative view. The balance of evidence suggests a wait-and-see stance rather than a clearly bullish or deeply bearish outlook.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started